Occasional nonspecific staining of prostate cancer cells with high molecular weight cytokeratin (HMWCK) can lead to false-negative diagnoses. We compared p63 and HMWCK immunostaining to check their specificity for basal cell identification. Out of 6887 prostate cancer cases sent in consultation to one of the authors over 1.5 years, we identified 22 (0.3%) cases with HMWCK labeling of cancer cells, including 20 needle biopsies and 2 transurethral resections of prostate (TURP). Cases were sent in consultation because of the confusing immunostaining pattern, where prostate cancer cells labeled with HMWCK at the outside institutions. In 6 cases, p63 immunostains were also received from the outside institution, whereas in the remaining 16 cases p63 immunohistochemistry was performed at our institution. In 14 cases, we used either an extra destained hematoxylin and eosin slide or a negative control slide for immunohistochemistry with antibodies to p63, and in the 2 remaining cases submitted unstained slides were used. The Gleason scores were 3+3 = 6 in 20 cases and 4+4 = 8 in 2 cases. The size of the tumor on needle biopsy ranged from 0.5 to 6.0 mm (mean 1 mm) and on the 2 TURP cases consisted of 44 and 68 cancer glands, respectively. The number of tumor cells positive for HMWCK in each of the needle biopsy cases ranged from 3 to 48 (mean 13 cells), whereas on the 2 TURP cases 26 and 10 cells were labeled with HMWCK. Corresponding stains for p63 on the same cases were negative in 18 cases. In 3 of 4 cases, p63 labeled 1, 1, and 2 tumor cells, respectively. The fourth case had 5 positive cells on p63 staining with 4 positive for HMWCK. To assess whether overstaining was a factor, we evaluated the intensity of HMWCK staining in the basal cells of the benign glands, which was moderate in 6 and strong in 16 cases. The cytoplasm of benign secretory cells showed focal weak (n = 3), diffuse weak (n = 1), and focal moderate (n = 2) staining for HMWCK. HMWCK labeling of prostate cancer cells is uncommon and does not seem to be solely attributable to overstaining. p63 is a more specific marker for basal cells than HMWCK, with less labeling of tumor cells. Recognition of this phenomenon and performing stains for p63 when it occurs can help prevent underdiagnosing prostatic carcinoma. FIGURE 2. A, Adenocarcinoma of the prostate, Gleason grade 4+4 = 8. B, Numerous cancer cells are labeled with antibody to high molecular weight cytokeratin.
I mmunohistochemistry for basal cell markers namely high molecular weight cytokeratin (HMWCK) and p63 is a useful adjunct in the diagnosis of limited prostate carcinoma. 5, 6 Prostate carcinoma with very rare exception lacks basal cells and most benign mimickers of prostate cancer demonstrate a basal cell layer, although in some cases it may be focal and patchy or in a small focus even negative. 7 We have noted in our consultation material cases of unequivocal prostatic adenocarcinoma on routine hematoxylin and eosin (H&E) stained sections that labeled at the outside institution with antibodies for HMWCK. As a result of focal nonspecific staining of cancer cells for HMWCK in a nonbasal cell distribution, contributing pathologists were unsure of the diagnosis and sought consultation. The following study was undertaken to evaluate this phenomenon in a more systematic fashion and compare in these cases p63 immunoreactivity to determine if it exhibited more specific basal cell labeling.
MATERIALS AND METHODS
Out of 6887 prostate cancer cases sent in consultation to one of the authors (J.I.E.) over a period of 1.5 years (approximately 50% accompanied by immunohistochemical stains for HMWCK), we identified 22 (0.3%) cases of prostate cancer with nonspecific HMWCK labeling of cancer cells. Specimens included 20 needle biopsies and 2 transurethral resections of prostate (TURP). The cases were submitted to us for review because of the confusing immunostaining pattern, where cells thought to be cancerous were labeled with HMWCK. In all cases, HMWCK immunohistochemistry was carried out at the outside institutions. In 6 cases, p63 immunostaining was also performed at the outside institutions with the remaining 16 cases stained for p63 (predilute, Ventana, Tucson, AZ) at our institution. In 14 cases, we used either an extra destained H&E slide or a negative control slide for immunohistochemistry with antibodies to p63, and in the 2 remaining cases unstained slides were used (Table 1) . 1 The number of cancer cells positive for HMWCK and p63 was counted. To ascertain whether overstaining could have contributed to the nonspecific staining of the cancer cells, we evaluated the intensity of HMWCK staining in the basal cells of the surrounding benign glands and whether there was any nonspecific labeling of the luminal cells of benign secretory cells. Statistics were performed using STATA version 8.0 (College Station, TX).
RESULTS
The Gleason scores of the tumors were 3+3 = 6 in 20 cases and 4+4 = 8 in the remaining 2 cases ( Figs. 1 and 2 ). The size of the tumor on needle biopsy ranged from 0.5 to 6.0 mm (mean 1 mm) and on the 2 TURP cases consisted of 44 and 68 cancer glands, respectively. The number of tumor cells positive for HMWCK in each of the needle biopsy cases ranged from 3 to 48 (mean 13 cells), whereas on the 2 TURP cases 26 and 10 cells were labeled with HMWCK (Figs. 3 and 4) . Corresponding stains for p63 on the same cases were negative in 18 cases ( Fig. 5 ). In 3 of 4 cases, p63 labeled 1, 1, and 2 tumor cells, respectively ( Fig. 6 ). The fourth case had 5 positive cells on p63 staining with 4 positive for HMWCK. The differences between HMWCK and p63 in terms of the number of cases with aberrant staining and the number of cells that were positive were statistically significant (P<0.01 and P = 0.01), respectively. The tumors that showed positivity with p63 were ones where p63 immunohistochemistry was performed at our institution. In 1 case, tumor cells labeled with HMWCK demonstrated perineural invasion ( Fig. 7) .
The intensity of HMWCK staining in the basal cells of the surrounding benign glands was moderate in 6 and strong in 16 cases. The cytoplasm of benign secretory cells showed focal weak (n = 3), diffuse weak (n = 1), and focal moderate (n = 2) staining for HMWCK. 
DISCUSSION
In the current era of prostate-specific antigen screening and extended needle biopsy sampling, small foci of prostatic carcinoma are commonly identified on needle biopsy. Approximately 5% of prostate needle biopsies are diagnosed as atypical, suspicious for carcinoma. 3 In some of these cases, mimickers, such as atrophy, high grade prostatic intraepithelial neoplasia (HGPIN), or adenosis, cannot be excluded. Mechanical distortion of glands as a result of crush artifact on needle biopsy or cautery artifact on TURP can further lead to a nondiagnostic atypical diagnosis. In other cases, there are so few glands with atypical architectural or cytologic features that a confident diagnosis of carcinoma cannot be rendered. In cases where the H&E morphology is highly suspicious for prostate cancer yet not diagnostic for cancer, negative immunoreactivity for basal cell markers (HMWCK and/or p63) can provide the extra support to arrive at a definitive malignant diagnosis. 6, 7, 10, 11, 13 Conversely, in less atypical cases where one of the benign mimickers of cancer is favored, positive staining can result in a confident benign diagnosis. 2, 4 It is widely recognized that various benign or precancerous lesions of the prostate, especially in a small focus on needle biopsy, may lack basal cell staining (ie, false negatives). 7 The most common include partial atrophy, HGPIN, and adenosis. Consequently, negative immunoreactivity for HMWCK or p63 in a small focus of atypical glands must be interpreted cautiously in light of the H&E appearance of the lesion.
What is less well-known is that cancer can rarely express basal cell markers (ie, false positives) in various staining patterns. 9 The rarest manifestation of this phenomenon is true basal cell staining in lesions that by H&E are diagnostic of carcinoma. Staining in a basal cell pattern can be explained by the possibility of retention of basal cells by early invasive cancer or that some glands seem to be outpouchings of HGPIN. 9 The diagnosis of carcinoma in the presence of true basal staining should be made with extreme caution only when the cancer is unequivocal and typically confirmed by expert consultation.
A more common type of false positive staining with basal cell markers is that prostate carcinoma cells label with HMWCK and less so with p63 in a nonbasal cell distribution. In a few earlier studies, it was noted in a few cases that scattered tumor cells stained with basal cell markers in high grade prostatic carcinoma and in metastatic foci, ruling out the possibility that these HMWCK positive cells could be outpouchings of HGPIN. 5, 8, 12, 19 It was speculated that perhaps this phenomenon occurred secondary to altered gene expression in prostate carcinoma. Most of the cases of prostate carcinomas showing false positive staining with HMWCK were high grade. In the current study, we describe this phenomenon in 22 cases of primary tumors, which include 20 prostate needle biopsies and 2 transurethral resections of prostate. The majority of our cases were Gleason score 6 ( Table 1) . Another theoretically possible explanation for our findings that is not supported by the histologic findings is that some benign glands were destroyed or replaced by carcinoma.
Some antigen retrieval methods have been implicated in nonspecific staining of prostate cancer cells by basal cell markers. 14, 16 It was noted that the hot plate antigen retrieval method though better for the overall staining, caused nonspecific immunoreactivity in the tumor cells. The pepsin predigestion and microwave retrieval methods did not cause this phenomenon, however, some benign acinar basal cells failed to stain with these methods. 16 To assess whether overstaining was a factor in the tumor cells labeling with HMWCK, we evaluated the intensity of HMWCK staining in the basal cells of the benign glands. Six cases had only moderately intense staining of basal cells in the benign glands and 16 cases showed strong intensity of staining. The number or intensity of the tumor cells labeling with HMWCK did not seem to be affected by the intensity of the background basal cell staining in surrounding benign glands. Overstaining was also assessed by examining the cytoplasm of benign secretory cells. There was focal weak staining seen in 3 cases, diffuse weak staining in 1 case, and focal moderate staining in only 2 cases, such that these findings also suggest that this type of false positive staining for basal cells is not solely attributable to overstaining. A weakness of this study is that we do not have the data on antibody clone, or the type used for HMWCK staining, or what antigen retrieval methods were used as the HMWCK staining was performed at outside institutions.
It has been demonstrated that using both p63 and HMWCK increases the sensitivity for the identification of basal cells in benign glands. 15, 17, 18 On the basis of our current study, p63 seems to have greater specificity compared with HMWCK, as well. Of the 22 cases with nonspecific staining for HMWCK, only 4 cases were positive for p63 with typically fewer p63 positive cells. Recognition of nonspecific cancer staining for HMWCK and performing stains for p63 when it occurs can help prevent an erroneous benign diagnosis. Careful attention to the nature of the HMWCK staining can also minimize the potential of mislabeling a focus as benign, with staining of cancer cells in a nonbasal cell distribution not having the same impact as true basal cell immunoreactivity. 
